BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20042505)

  • 1. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu.
    Lucas TM; Lyddon TD; Cannon PM; Johnson MC
    J Virol; 2010 Mar; 84(6):2666-74. PubMed ID: 20042505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail.
    Lucas TM; Janaka SK; Stephens EB; Johnson MC
    PLoS One; 2012; 7(12):e51741. PubMed ID: 23284757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional complementation of a model target to study Vpu sensitivity.
    Janaka SK; Faurot J; Johnson MC
    PLoS One; 2013; 8(6):e68507. PubMed ID: 23840857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequences in gibbon ape leukemia virus envelope that confer sensitivity to HIV-1 accessory protein Vpu.
    Janaka SK; Lucas TM; Johnson MC
    J Virol; 2011 Nov; 85(22):11945-54. PubMed ID: 21917962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors.
    Christodoulopoulos I; Droniou-Bonzom ME; Oldenburg JE; Cannon PM
    Retrovirology; 2010 Jan; 7():4. PubMed ID: 20102634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
    Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
    Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
    Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.
    Christodoulopoulos I; Cannon PM
    J Virol; 2001 May; 75(9):4129-38. PubMed ID: 11287562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
    Song YE; Olinger GY; Janaka SK; Johnson MC
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites.
    Lucas TM; Lyddon TD; Grosse SA; Johnson MC
    Virology; 2010 Sep; 405(2):548-55. PubMed ID: 20655565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Envelope proteins of spleen necrosis virus form infectious human immunodeficiency virus type 1 pseudotype vector particles, but fail to incorporate upon substitution of the cytoplasmic domain with that of Gibbon ape leukemia virus.
    Stitz J; Wolfrum N; Buchholz CJ; Cichutek K
    J Gen Virol; 2006 Jun; 87(Pt 6):1577-1581. PubMed ID: 16690921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.
    Kraus MH; Parrish NF; Shaw KS; Decker JM; Keele BF; Salazar-Gonzalez JF; Grayson T; McPherson DT; Ping LH; Anderson JA; Swanstrom R; Williamson C; Shaw GM; Hahn BH
    Virology; 2010 Feb; 397(2):346-57. PubMed ID: 20003995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
    Farrell KB; Ting YT; Eiden MV
    J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
    Sandrin V; Muriaux D; Darlix JL; Cosset FL
    J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles.
    Merten CA; Stitz J; Braun G; Poeschla EM; Cichutek K; Buchholz CJ
    J Virol; 2005 Jan; 79(2):834-40. PubMed ID: 15613311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
    Oliveira NM; Trikha R; McKnight Á
    Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release.
    Noble B; Abada P; Nunez-Iglesias J; Cannon PM
    J Virol; 2006 Mar; 80(6):2924-32. PubMed ID: 16501101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Compound Inhibitors of HIV-1
    Robinson CA; Lyddon TD; Gil HM; Evans DT; Kuzmichev YV; Richard J; Finzi A; Welbourn S; Rasmussen L; Nebane NM; Gupta VV; Ananthan S; Cai Z; Wonderlich ER; Augelli-Szafran CE; Bostwick R; Ptak RG; Schader SM; Johnson MC
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.
    Bour S; Strebel K
    J Virol; 1996 Dec; 70(12):8285-300. PubMed ID: 8970948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.